Ampiroxicam
![]() | |
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
(RS)-Ethyl 1-[2-methyl-1,1-dioxo-3-(pyridin-2-ylcarbamoyl)benzo[e]thiazin-4-yl]oxyethyl carbonate | |
| Clinical data | |
| AHFS/Drugs.com | International Drug Names |
| Routes of administration | Oral |
| Legal status | |
| Legal status |
|
| Identifiers | |
| CAS Number |
99464-64-9 |
| ATC code | none |
| PubChem | CID 2176 |
| ChemSpider |
2091 |
| UNII |
0PV32JZB1J |
| KEGG |
D01397 |
| ChEBI |
CHEBI:31210 |
| ChEMBL |
CHEMBL1909052 |
| Chemical data | |
| Formula | C20H21N3O7S |
| Molar mass | 447.46 g/mol |
| Chirality | Racemic mixture |
| |
| |
| | |
Ampiroxicam (INN) is a non-steroidal anti-inflammatory drug. It is a prodrug of piroxicam.[1]
References
- ↑ Carty TJ, Marfat A, Moore PF, Falkner FC, Twomey TM, Weissman A (July 1993). "Ampiroxicam, an anti-inflammatory agent which is a prodrug of piroxicam". Agents Actions 39 (3-4): 157–65. doi:10.1007/BF01998969. PMID 8304243.
| ||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Tuesday, April 19, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.

